Indication

Proteus meningitis

Proteus meningitis is a severe, uncommon bacterial infection of the central nervous system characterized by inflammation of the meninges and spinal cord due to species of the gram-negative bacillary genus *Proteus*, most frequently *Proteus mirabilis*. Read more about Proteus meningitis

16 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Proteus meningitis therapies.

Showing 1–9 of 16 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Proteus meningitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Proteus meningitis.

Proteus meningitis is a severe, uncommon bacterial infection of the central nervous system characterized by inflammation of the meninges and spinal cord due to species of the gram-negative bacillary genus *Proteus*, most frequently *Proteus mirabilis*.

The condition predominantly affects neonates and infants through hematogenous seeding, though it can also occur in adults with risk factors such as prior neurosurgical intervention, cranial trauma, structural urinary tract disease, or immunocompromising conditions.

Pathophysiologically, it produces purulent cerebrospinal fluid pleocytosis, microvascular thrombosis, and severe tissue necrosis.

It is clinically distinguished by an aggressive acute course with high rates of intracranial complications, including cerebral abscess formation, ventriculitis, hydrocephalus, and lasting neurological deficits.

Personalize your experience

Follow Proteus meningitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it